Outlook Therapeutics, Inc. announced resignation of Joerg Windisch as a Class II member of the company’s board of directors effective from July 18, 2019. Dr. Windisch indicated that his decision to resign from the board was not a result of any disagreement with the company on any matter relating to the Company’s operations, policies or practices.